MetLife (MET) to Release Quarterly Earnings on Wednesday

MetLife (NYSE:MET) will be posting its quarterly earnings results after the market closes on Wednesday, May 1st. Analysts expect MetLife to post earnings of $2.00 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The business had revenue of $18.72 billion during the quarter, compared to the consensus estimate of $18.07 billion. On average, analysts expect MetLife to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

MetLife Price Performance

MET opened at $72.23 on Wednesday. The company’s 50 day simple moving average is $71.28 and its 200-day simple moving average is $67.02. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $52.22 billion, a P/E ratio of 39.47, a price-to-earnings-growth ratio of 0.53 and a beta of 1.04. MetLife has a one year low of $48.95 and a one year high of $74.68.

MetLife Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 3.02%. This is an increase from MetLife’s previous quarterly dividend of $0.52. MetLife’s dividend payout ratio (DPR) is 113.66%.

Insider Buying and Selling at MetLife

In related news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ramy Tadros sold 4,026 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on MET shares. Wells Fargo & Company lifted their price target on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Morgan Stanley lifted their price target on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Piper Sandler boosted their target price on MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. UBS Group lowered their target price on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research report on Monday, February 5th. Finally, Keefe, Bruyette & Woods raised their price target on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.23.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.